Omnicell [OMCL] vs Veeva Systems [VEEV] Detailed Stock Comparison

Omnicell

Veeva Systems
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Omnicell wins in 7 metrics, Veeva Systems wins in 12 metrics, with 0 ties. Veeva Systems appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Omnicell | Veeva Systems | Better |
---|---|---|---|
P/E Ratio (TTM) | 61.90 | 60.84 | Veeva Systems |
Price-to-Book Ratio | 1.14 | 7.31 | Omnicell |
Debt-to-Equity Ratio | 30.42 | 1.29 | Veeva Systems |
PEG Ratio | 1.24 | 3.79 | Omnicell |
EV/EBITDA | 19.00 | 48.57 | Omnicell |
Profit Margin (TTM) | 2.01% | 27.29% | Veeva Systems |
Operating Margin (TTM) | 2.80% | 28.71% | Veeva Systems |
EBITDA Margin (TTM) | 2.80% | 28.71% | Veeva Systems |
Return on Equity | 1.87% | 13.70% | Veeva Systems |
Return on Assets (TTM) | 0.49% | 7.24% | Veeva Systems |
Free Cash Flow (TTM) | $134.93M | $1.09B | Veeva Systems |
1-Year Return | -28.39% | 41.85% | Veeva Systems |
Price-to-Sales Ratio (TTM) | 1.24 | 16.36 | Omnicell |
Enterprise Value | $1.41B | $42.24B | Veeva Systems |
EV/Revenue Ratio | 1.22 | 14.23 | Omnicell |
Gross Profit Margin (TTM) | 43.94% | 75.26% | Veeva Systems |
Revenue per Share (TTM) | $25 | $18 | Omnicell |
Earnings per Share (Diluted) | $0.50 | $4.87 | Veeva Systems |
Beta (Stock Volatility) | 0.88 | 0.98 | Omnicell |
Omnicell vs Veeva Systems Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Omnicell | -1.39% | 0.59% | -5.60% | 5.53% | -3.42% | -31.14% |
Veeva Systems | 1.17% | 2.31% | 6.00% | 6.68% | 39.59% | 42.35% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Omnicell | -28.39% | -58.34% | -62.99% | 0.36% | 126.07% | 225.72% |
Veeva Systems | 41.85% | 98.39% | -2.13% | 1,056.93% | 575.29% | 575.29% |
News Based Sentiment: Omnicell vs Veeva Systems
Omnicell
News based Sentiment: MIXED
October brought a blend of positive and negative developments for Omnicell, including insider buying, a 'Buy' rating, but also recent price declines and a significant year-over-year loss in market capitalization. The upcoming Q3 earnings report on October 29th is a key catalyst that will shape the investment narrative.
Veeva Systems
News based Sentiment: MIXED
October presented a mixed picture for Veeva, with strong financial results and growing industry adoption offset by notable insider selling and a rating downgrade. The upcoming Investor Day will be critical for clarifying the company's strategy and addressing investor concerns, making this a significant month for the investment story.
Performance & Financial Health Analysis: Omnicell vs Veeva Systems
Metric | OMCL | VEEV |
---|---|---|
Market Information | ||
Market Cap | $1.46B | $48.56B |
Market Cap Category | Small cap | Large cap |
10 Day Avg. Volume | 350,293 | 1,277,350 |
90 Day Avg. Volume | 488,778 | 1,488,867 |
Last Close | $30.52 | $299.76 |
52 Week Range | $22.66 - $55.75 | $200.30 - $303.47 |
% from 52W High | -45.26% | -1.22% |
All-Time High | $187.29 (Nov 22, 2021) | $343.96 (Aug 02, 2021) |
% from All-Time High | -83.70% | -12.85% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.05% | 0.17% |
Quarterly Earnings Growth | 0.51% | 0.17% |
Financial Health | ||
Profit Margin (TTM) | 0.02% | 0.27% |
Operating Margin (TTM) | 0.03% | 0.29% |
Return on Equity (TTM) | 0.02% | 0.14% |
Debt to Equity (MRQ) | 30.42 | 1.29 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | $27.22 | $40.51 |
Cash per Share (MRQ) | $8.69 | $39.07 |
Operating Cash Flow (TTM) | $147.75M | $1.35B |
Levered Free Cash Flow (TTM) | $85.81M | $1.10B |
Dividends | ||
Last 12-Month Dividend Yield | N/A | N/A |
Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Omnicell vs Veeva Systems
Metric | OMCL | VEEV |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 61.90 | 60.84 |
Forward P/E | 17.19 | 43.83 |
PEG Ratio | 1.24 | 3.79 |
Price to Sales (TTM) | 1.24 | 16.36 |
Price to Book (MRQ) | 1.14 | 7.31 |
Market Capitalization | ||
Market Capitalization | $1.46B | $48.56B |
Enterprise Value | $1.41B | $42.24B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 1.22 | 14.23 |
Enterprise to EBITDA | 19.00 | 48.57 |
Risk & Other Metrics | ||
Beta | 0.88 | 0.98 |
Book Value per Share (MRQ) | $27.22 | $40.51 |
Financial Statements Comparison: Omnicell vs Veeva Systems
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | OMCL | VEEV |
---|---|---|
Revenue/Sales | $290.56M | $759.04M |
Cost of Goods Sold | $162.88M | $173.82M |
Gross Profit | $127.68M | $585.22M |
Research & Development | $21.57M | $184.03M |
Operating Income (EBIT) | $8.12M | $233.73M |
EBITDA | $29.77M | $243.55M |
Pre-Tax Income | $10.45M | $298.82M |
Income Tax | $4.81M | $70.63M |
Net Income (Profit) | $5.64M | $228.19M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | OMCL | VEEV |
---|---|---|
Cash & Equivalents | $386.83M | $1.96B |
Total Current Assets | $839.67M | $6.71B |
Total Current Liabilities | $607.53M | $1.46B |
Long-Term Debt | $199.72M | $66.57M |
Total Shareholders Equity | $1.26B | $6.21B |
Retained Earnings | $375.87M | $3.68B |
Property, Plant & Equipment | $130.63M | $122.23M |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | OMCL | VEEV |
---|---|---|
Operating Cash Flow | $28.34M | $810.54M |
Capital Expenditures | $-11.17M | N/A |
Free Cash Flow | $10.19M | $877.16M |
Debt Repayment | N/A | N/A |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | OMCL | VEEV |
---|---|---|
Shares Short | 1.97M | 5.41M |
Short Ratio | 3.80 | 3.60 |
Short % of Float | 0.06% | 0.04% |
Average Daily Volume (10 Day) | 350,293 | 1,277,350 |
Average Daily Volume (90 Day) | 488,778 | 1,488,867 |
Shares Outstanding | 46.38M | 162.58M |
Float Shares | 44.82M | 150.41M |
% Held by Insiders | 0.02% | 0.09% |
% Held by Institutions | 1.05% | 0.89% |
Dividend Analysis & Yield Comparison: Omnicell vs Veeva Systems
Metric | OMCL | VEEV |
---|---|---|
Last 12-Month Dividend | N/A | N/A |
Last 12-Month Dividend Yield | N/A | N/A |
3-Year Avg Annual Dividend | N/A | N/A |
3-Year Avg Dividend Yield | N/A | N/A |
3-Year Total Dividends | N/A | N/A |
Ex-Dividend Date | N/A | N/A |